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Purpose: Astragalus and Euonymus alatus herb couple is
the main herb couple in many classical prescriptions for dia-
betes mellitus, which has been used to treat diabetes mellitus
for thousands of years inChina. In this studyweprovide exper-
imental evidence of the two herbs for treatment diabetes at
the level of in vivo and gene expression. And made ingre-
dients prediction of diabetes treatment from Astragalus and
Euonymus alatus.
Methods:ADME/T expert systemand feature selection data
mining methods with real-time PCR were used.
Results: 10 and 13 ingredients were found from Astragalus
and Euonymus alatus respect which bioavailabilities exceed
50%. Add other ingredients according reports, we get action
target pot of the two herb. The ingredients in Euonymus ala-
tus relative targets are ABL1, ACE, CYP2C8, DAPK1, ESR1, GCK,
GSTM1, HMGCR, IL2, PPARG, RBP4, REN, SHB G, SOD2. Thor-
ough Sensitivity and redundancy analysis, we found SHBG,
REN, ABL1, ACE, HMGCR are the key protein in the network.
The ingredients in Astragalus relative targets are ABL1, ACE,
CYP2C8, DAPK1, ESR1, GCK, GSTM1, HMGCR, IL2, PPARG, RBP4,
REN, SHBG, SOD2, IGF1, PPARA, RBP4. Thorough Sensitivity
and redundancy analysis, REN, SHBG, ESR1, RBP4, HMGCR, IL2
were foundvery key in thenetwork. Fromtheviewof the entire
network, ESR1, RBP4, HMGCR, PPARG, REN were the most key
targets. The expression of ESR1 and Ren gene in the kidney
of diabetic model of kk-A(y) mice increased with the study of
real-time PCR.
Conclusion: ESR1, RBP4, HMGCR, PPARG, REN may be
the key targets of diabetes drug action. And the Astragalus
and Euonymus alatus are full of research and development
value.
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Palmiwon attenuates hepatic lipid
accumulation and hyperlipidemia in a
menopausal rat model
Byoung Seob Ko, Hiroa Ko, Jin Ah Ryuk,
Hye Won Lee
Korea Institute of Oriental Medicine
Purpose: We examined the phytoestrogenic effects of
Palmiwon on breast carcinoma, lipid accumulation in methyl-
-cyclode xtrin-induced HepG2 cells, and lipid-related disease
in a rat model of menopausal hyperlipidemia.
Methods: An E-screen assay was used to screen for phy-
toestrogens, especially for those with anti-estrogenic activity,
in MCF- 7 cells. Numerous experiments were conducted in
HepG2 cells to examine the estrogenic effects of Palmiwon
on lipid accumulation. Oil Red O staining and intracellular
cholesterol analyses were used to quantify cellular cholesterol
levels. A 3-hydroxy-3-methyl glutaryl coenzyme A reductase
assay was used to measure enzyme activity. The levels of
phosphorylated AMP-activated protein kinases and products
of genes involved in cholesterol synthesis were measured by
Western blotting. For in vivo analyses, we used a rat model of
menopausal hyperlipidemia. A number of targets associated
with lipid-related diseases, such as retroperitoneal and peri-
renal fat accumulation, serum lipids, the atherogenic index,
cardiac risk factors, lumen diameter, media thickness, and
nonalcoholic steatohepatitis scoreswere examined to conﬁrm
the estrogenic effects of Palmiwon.
Results: Palmiwon showed anti-estrogenic activity in MCF-
7 cells. Palmiwon treatment signiﬁcantly decreased lipid
accumulation, total cholesterol levels, and low-density/very-
low-density lipoprotein levels in HepG2 cells. Moreover,
Palmiwon reversed the effects of methyl--cyclodextrin on
sterol regulatory element binding protein-2 and low-density
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